Application no. and date | 17748642.0 (espacenet) (Federated) (European Patent Register), 20170717 | Patent/reg. no. and date | DK/EP 3484926, 20220216 | Publication date | 20190522 | Priority no. and date | EP 16001564, 20160715 | EP pub. no. and date |
EP 3484926 20190522 | Effective date | | Applicant/owner | OGD2 Pharma, 3, chemin du Pressoir Chênaie
44100 Nantes, FR | Applicant ref. no. | V2205-003-DK | Inventor | ASSOULINE, Brigitte, 12 Rue de Sébastopol
92400 COURBEVOIE, FR, TERME, Mickaël, 200 avenue de Mindin
44250 Saint-Brevin-les-Pins, FR, LE DOUSSAL, Jean-Marc, 3 chemin du Pressoir Chênaie
44100 Nantes, FR, DORVILLIUS, Mylene, 3 chemin du Pressoir Chênaie
44100 Nantes, FR | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61P 11/00 (2006.01) , A61P 13/12 (2006.01) , A61P 15/00 (2006.01) , A61P 17/00 (2006.01) , A61P 21/00 (2006.01) , A61P 25/00 (2006.01) , A61P 27/02 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , C07K 16/30 (2006.01) | Title | HUMANISERET ANTISTOF MOD O-ACETYLERET GD2 GANGLIOSID (OACGD2) | Int. application no. | EP2017000855 | Int. publication no. | WO2018010846 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|